It is a business services foreign private limited company based in Mumbai, Maharashtra, India, established in 2019.
2019 | Mumbai, Maharashtra, India | ActiveRedgrove Pharmaceuticals India Private Limited, a active foreign private limited company, was established on 22 May 2019 in Mumbai, Maharashtra, India. Engaging in business support services within the support service to organizations sector, it holds CIN: U74999MH2019FTC325669. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Avni Ajit Shah (Additional Director), Firuzi Bahadur Langrana (Director). Past directors included Ajit Jyotishkumar Shah. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plant 13, Extension Office, Nr Ginger Godrej Soaps Eastern Express Highway,Pirojsha Nagar,, Vikhroli E, Mumbai, Maharashtra, 400079.
U74999MH2019FTC325669
325669
22 May 2019
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Redgrove Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avni Ajit Shah | Additional Director | 24 Mar 2024 | Current |
| Firuzi Bahadur Langrana | Director | 22 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Redgrove Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.07% increase. The company also saw a substantial improvement in profitability, with a 14.07% increase in profit. The company's net worth Soared by an impressive increase of 54.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Redgrove Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Redgrove Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Redgrove Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redgrove Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Redgrove Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Redgrove Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Avni Ajit Shah was appointed as a Additional Director was appointed as a Additional Director on 24 Mar 2024 & has been associated with this company since 1 year 8 months . was completed.
The activity Firuzi Bahadur Langrana was appointed as a Director was appointed as a Director on 22 May 2019 & has been associated with this company since 6 years 6 months . was completed.
The activity Redgrove Pharmaceuticals India Private Limited was registered on 22 May 2019 with Roc Mumbai & aged 6 years 6 months as per MCA records. was completed.
The CIN of Redgrove Pharmaceuticals India Private Limited is U74999MH2019FTC325669.
Redgrove Pharmaceuticals India Private Limited is headquartered at Plant 13, Extension Office, Nr Ginger Godrej Soaps Eastern Express Highway,Pirojsha Nagar,, Vikhroli E, Mumbai, Maharashtra, 400079.
Redgrove Pharmaceuticals India Private Limited was incorporated on 22 May 2019.
The current directors of Redgrove Pharmaceuticals India Private Limited are
The primary industry of Redgrove Pharmaceuticals India Private Limited is Support Service To Organizations.
Redgrove Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Redgrove Pharmaceuticals India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX